HomeAbout

TL;DR CNBC


The ADHD drug market is already stretched thin. Now it's facing a back-to-school supply strain - TL;DR CNBC

The ADHD drug market is already stretched thin. Now it's facing a back-to-school supply strain

Publishing timestamp: 2023-08-26 08:00:02


Summary

The article discusses the ongoing shortage of Adderall, a widely used medication for attention deficit hyperactivity disorder (ADHD), in the United States. The shortage has been ongoing for 10 months and may potentially worsen as children head back to school. The lack of transparency in the pharmaceutical industry makes it difficult to predict when the shortages will end or find a resolution. The article highlights the concerns of experts and the impact on individuals who rely on ADHD medications. The article also mentions the challenges in increasing production and the finger-pointing between agencies and manufacturers regarding the cause of the shortages.


Sentiment: NEGATIVE

Tickers: NOV.N-CHNVSAMRXTEVATEVA-IL

Keywords: drug useattention deficit disordersmental healthteva pharmaceutical industries ltdbusiness newsbusinesspharmaceuticalsattention deficit hyperactivity disorderhealth care industrysciencenovartis agunited statesbiotechnologybiotech and pharmaceuticals

Source: https://www.cnbc.com/2023/08/26/adhd-drug-market-back-to-school-supply-strain.html


Developed by Leo Phan